These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 210361)

  • 21. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of glycosylated analogs of somatostatin.
    Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
    Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep.
    Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F
    Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 27. Somatostatin.
    Efendić S; Hökfelt T; Luft R
    Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
    [No Abstract]   [Full Text] [Related]  

  • 28. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size.
    Veber DF; Holly FW; Nutt RF; Bergstrand SJ; Brady SF; Hirschmann R; Glitzer MS; Saperstein R
    Nature; 1979 Aug; 280(5722):512-4. PubMed ID: 460433
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid conversion of somatostatin to active metabolite in human plasma.
    Märki F; Schenkel L; Petrack B; Czernik AJ; Ansell J; Allen M; Brundish DE; Martin JR; McMartin C; Peters GE; Wade R
    FEBS Lett; 1981 May; 127(1):22-4. PubMed ID: 6113990
    [No Abstract]   [Full Text] [Related]  

  • 30. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.
    Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH
    Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
    Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
    Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone.
    Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K
    Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
    Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro.
    Barden N; Lavoie M; Dupont A; Côté J; Côté JP
    Endocrinology; 1977 Aug; 101(2):635-8. PubMed ID: 328268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of effects of somatostatin antiserum on growth hormone and insulin secretion.
    Tannenbaum GS; Epelbaum J; Colle E; Brazeau P; Martin JB
    Metabolism; 1978 Sep; 27(9 Suppl 1):1263-7. PubMed ID: 682990
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B-cell-selective somatostatin analog.
    Weir GC; Schwarz JA; Mathe CJ
    Metabolism; 1980 Jan; 29(1):68-70. PubMed ID: 6986012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin analogs with selected biologic activities.
    Brown M; Rivier J; Vale W
    Metabolism; 1976 Nov; 25(11 Suppl 1):1501-3. PubMed ID: 979656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.